Study on Chemical Hair Straighteners and Uterine Cancer Risk
This Act mandates a detailed government study on the potential link between the use of chemical hair straighteners and the increased incidence of uterine cancer. The study will specifically focus on women of color, where higher rates of this cancer have been observed. The goal is to determine if the Food and Drug Administration (FDA) should impose new safety testing requirements on manufacturers of these products, potentially enhancing consumer safety.
Key points
Directs the Department of Health and Human Services (HHS) to conduct a study on the relationship between chemical hair straighteners and uterine cancer.
The study must specifically focus on the increased incidence of uterine cancer among women of color.
The research will assess whether the FDA should impose additional safety testing requirements on hair straightener manufacturers.
A final report detailing the study results must be submitted to Congress within 2 years of the Act's enactment.
Expired
Citizen Poll